Di Nisio, M., van Es, N. & Büller, H. R. Deep vein thrombosis and pulmonary embolism. Lancet. 388(10063), 3060–3073 (2016).
Rali, P. M. & Criner, G. J. Submassive pulmonary embolism. Am. J. Respir Crit. Care Med. 198(5), 588–598 (2018).
Millington, S. J. et al. Excessive and intermediate threat pulmonary embolism in the ICU. Intensive Care Med. 50(2), 195–208 (2024).
Righini, M., Robert-Ebadi, H. & Le Gal, G. Analysis of acute pulmonary embolism. J. Thromb. Haemost. 15(7), 1251–1261 (2017).
Yazıcı, S. et al. Relation of distinction nephropathy to adversarial occasions in pulmonary emboli sufferers identified with distinction CT. Am. J. Emerg. Med. 34(7), 1247–1250 (2016).
Williams, L. S., Walker, G. R., Loewenherz, J. W. & Gidel, L. T. Affiliation of distinction and acute kidney damage in the critically in poor health: a propensity-matched examine. Chest. 157(4), 866–876 (2020).
Matheny, M. E., Whicher, D. & Thadaney Israni, S. Synthetic intelligence in well being care: a report from the nationwide academy of medication. JAMA 323(6), 509–510 (2020).
Nguyen, G. & Dlugolinsky, S. Machine learning and deep learning frameworks and libraries for large-scale information mining: a survey. Artif. Intell. Rev. 52, 77–124 (2019).
Handelman, G. S. et al. eDoctor: machine learning and the future of medication. J. Intern. Med. 284(6), 603–619 (2018).
Ngiam, Okay. Y. & Khor, I. W. Large information and machine learning algorithms for health-care supply. Lancet Oncol. 20(5), e262–e273 (2019).
Haug, C. J. & Drazen, J. M. Synthetic intelligence and machine learning in scientific medication, 2023. N Engl. J. Med. 388(13), 1201–1208 (2023).
Yang, X. et al. Predicting the 10-Yr dangers of atherosclerotic heart problems in Chinese language inhabitants: the China-PAR Venture (Prediction for ASCVD Danger in China). Circulation. 134(19), 1430–1440 (2016).
Liu, W. et al. Analysis of acute pulmonary embolism and clot burden on CTPA with deep learning. Eur. Radiol. 30(6), 3567–3575 (2020).
Ma, X. et al. A multitask deep learning approach for pulmonary embolism detection and identification. Sci. Rep. 12(1), 13087 (2022).
Hunsaker, A. R. Deep learning and threat evaluation in acute pulmonary embolism. Radiology 302(1), 185–186 (2022).
Ma, M. et al. Predicting the molecular subtype of breast most cancers and figuring out interpretable imaging options utilizing machine learning algorithms. Eur. Radiol. 32(3), 1652–1662 (2022).
Freund, Y., Cohen-Aubart, F. & Bloom, B. Acute pulmonary embolism: a overview. JAMA. 328(13), 1336–1345 (2022).
Konstantinides, S. V. et al. 2019 ESC pointers for the prognosis and administration of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Coronary heart J. 41(4), 543–603 (2020).
Barco, S. et al. Age-sex particular pulmonary embolism-related mortality in the USA and Canada, 2000-18: an evaluation of the WHO mortality database and of the CDC a number of trigger of loss of life database. Lancet Respir Med. 9(1), 33–42 (2021).
Peris, M. et al. Medical traits and 3-month outcomes in most cancers sufferers with incidental versus clinically suspected and confirmed pulmonary embolism. Eur. Respir J. 58(1), 2002723 (2021).
Motamedi, F. et al. Accelerating large information evaluation by means of LASSO-random forest algorithm in QSAR research. Bioinformatics 38(2), 469–475 (2022).
Tseng, P. Y. et al. Prediction of the improvement of acute kidney damage following cardiac surgical procedure by machine learning. Crit. Care 24(1), 478 (2020).
Qiao, N. et al. Machine learning prediction of venous thromboembolism after surgical procedures of main sellar area tumors. Thromb. Res. 226, 1–8 (2023).
Wang, G. et al. Machine learning-based fashions for predicting mortality and acute kidney damage in crucial pulmonary embolism. BMC Cardiovasc. Disord. 23(1), 385 (2023).
Kearon, C. et al. Analysis of pulmonary embolism with d-dimer adjusted to scientific likelihood. N Engl. J. Med. 381(22), 2125–2134 (2019).
Klok, F. A. et al. Incidence of thrombotic issues in critically in poor health ICU sufferers with COVID-19. Thromb. Res. 191, 145–147 (2020).
Alba, G. A. et al. NEDD9 is a novel and modifiable mediator of platelet-endothelial adhesion in the pulmonary circulation. Am. J. Respir Crit. Care Med. 203(12), 1533–1545 (2021).
Özcan, S. et al. The prognostic worth of C-reactive protein/albumin ratio in acute pulmonary embolism. Rev. Make investments. Clin. 74(2), 097–103 (2022).
Zhou, Q., Xiong, X. Y. & Liang, Z. A. Creating a nomogram-based scoring device to estimate the threat of pulmonary embolism. Int. J. Gen. Med. 15, 3687–3697 (2022).
Bonaca, M. P. et al. Low-density lipoprotein ldl cholesterol decreasing with evolocumab and outcomes in sufferers with peripheral artery illness: insights from the FOURIER Trial (additional cardiovascular outcomes analysis with PCSK9 inhibition in topics with elevated threat). Circulation. 137(4), 338–350 (2018).
Hanff, T. C. et al. Thrombosis in COVID-19. Am. J. Hematol. 95(12), 1578–1589 (2020).
Lavatory, J., Spittle, D. A. & Newnham, M. COVID-19, immunothrombosis and venous thromboembolism: organic mechanisms. Thorax. 76(4), 412–420 (2021).
Poor, H. D. Pulmonary thrombosis and thromboembolism in COVID-19. Chest. 160(4), 1471–1480 (2021).
Righini, M. et al. Age-adjusted D-dimer cutoff ranges to rule out pulmonary embolism: the ADJUST-PE examine. JAMA 311(11), 1117–1124 (2014).
Suh, Y. J. et al. Pulmonary embolism and deep vein thrombosis in COVID-19: a scientific overview and meta-analysis. Radiology 298(2), E70–E80 (2021).
Medson, Okay. et al. Evaluating ‘scientific hunch’ towards scientific determination help programs (PERC rule, wells rating, revised Geneva rating and YEARS standards) in the prognosis of acute pulmonary embolism. BMC Pulm Med. 22(1), 432 (2022).
Kirsch, B. et al. Wells rating to foretell pulmonary embolism in sufferers with coronavirus illness 2019. Am. J. Med. 134(5), 688–690 (2021).
Stals, M. A. M. et al. Security and effectivity of diagnostic methods for ruling out pulmonary embolism in clinically related affected person subgroups: a scientific overview and individual-patient information meta-analysis. Ann. Intern. Med. 175(2), 244–255 (2022).
An, C. et al. Radiomics machine learning examine with a small pattern dimension: single random training-test set break up might result in unreliable outcomes. PLoS One 16(8), e0256152 (2021).
Vrudhula, A. et al. Machine learning and bias in medical imaging: alternatives and challenges. Circ Cardiovasc Imaging. 17(2), e015495. (2024).
McCabe, B. E. et al. Past pulmonary embolism; nonthrombotic pulmonary embolism as diagnostic challenges. Curr. Probl. Diagn. Radiol. 48(4), 387–392 (2019).
Asah, D. et al. Nonthrombotic pulmonary embolism from inorganic particulate matter and international our bodies. Chest 153(5), 1249–1265 (2018).
Daidone, M., Ferrantelli, S. & Tuttolomondo, A. Machine learning purposes in stroke medication: developments, challenges, and future prospectives. Neural Regen Res. 19(4), 769–773 (2024).
O’Reilly-Shah, V. N. et al. Bias and moral issues in machine learning and the automation of perioperative threat evaluation. Br. J. Anaesth. 125(6), 843–846 (2020).